Polaryx Therapeutics, Inc. Common Stock (PLYX) — Net Asset Quality Index
Polaryx Therapeutics, Inc. Common Stock (PLYX) has a Net Asset Quality Index of 84.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $5.42 Million minus total liabilities of $855.00K yields net assets of $4.57 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Polaryx Therapeutics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Polaryx Therapeutics, Inc. Common Stock Net Asset Quality Index Over Time (2023–2025)
This chart shows how Polaryx Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the index stands at 84.2%, representing net assets of $4.57 Million against total assets of $5.42 Million USD. Explore cash efficiency ratio of Polaryx Therapeutics, Inc. Common Stock to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Polaryx Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Net Asset Quality Index for Polaryx Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Polaryx Therapeutics, Inc. Common Stock.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.2% | $4.57 Million | $5.42 Million | $855.00K | ▼ -10.0 pp |
| 2024 | 94.2% | $4.71 Million | $5.00 Million | $289.00K | ▲ +39.1 pp |
| 2023 | 55.2% | $1.28 Million | $2.31 Million | $1.04 Million | — |